STARTON THERAPEUTICS INC.

Profile

Company Names

STARTON THERAPEUTICS INC.
CHEMIOCARE INC.

Addresses

215 COLLEGE ROAD, SUITE #300, PARAMUS, NJ 07652

57 WEST 57TH STREET, 4TH FLOOR, NEW YORK, NY 10019

322 WEST 57TH STREET, APT. 35B, NEW YORK, NY 10019

Phone Numbers

800-449-5405
(800) 449-5405

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, PHARMACEUTICALS, OTHER HEALTH CARE

Year Incorporated:

2017

State Incorporated:

BRITISH COLUMBIA, CANADA

Total Amount Raised:

$10,737,604.00

Number of Funding Rounds:

9
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
9
2024-10-10 
$2,126,035.00 
$2,126,035.00 
$0.00 
Equity 
8
2023-10-01 
$970,930.00 
$970,930.00 
$0.00 
Equity 
7
2023-03-31 
$1,443,520.00 
$1,443,520.00 
$0.00 
Equity 
6
2023-01-18 
$1,023,417.00 
$1,023,417.00 
$0.00 
Equity 
5
2022-02-11 
$1,145,350.00 
$1,145,350.00 
$0.00 
Equity 
4
2021-10-19 
$1,145,375.00 
$1,145,375.00 
$0.00 
Equity 
3
2021-03-03 
$77,597.00 
$77,597.00 
$0.00 
Equity 
2
2019-12-20 
$2,038,703.00 
INDEFINITE 
INDEFINITE 
Equity 
1
2018-04-04 
$766,677.00 
INDEFINITE 
INDEFINITE 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
KENNETH 
 
ANDERSON 
DIRECTOR
ACETYLON PHARMACEUTICALS, INC.   |  ONCOPEP, INC.   |  ONE WORLD LAB, INC.   |  C4 THERAPEUTICS, INC.   |  ASPIRIANT, LLC   |  STARTON THERAPEUTICS INC.   |  NEXTRNA THERAPEUTICS, INC.   |  WINDOW THERAPEUTICS, INC.
ERIC 
 
BAUM 
DIRECTOR
KUSH BOTTLES, INC.   |  BIGRENTZ, INC.   |  KUSHCO HOLDINGS, INC.   |  CHEMIOCARE INC.   |  STARTON THERAPEUTICS INC.   |  UNRIVALED BRANDS, INC.
ASHER 
 
CHANAN-KHAN 
DIRECTOR
STARTON THERAPEUTICS INC.
KEITH 
 
DARRAGH 
EXECUTIVE OFFICER
STARTON THERAPEUTICS INC.
MOSES 
 
DODO 
DIRECTOR
STARTON THERAPEUTICS INC.
MOHAMAD 
 
HUSSEIN 
DIRECTOR
CHEMIOCARE INC.   |  STARTON THERAPEUTICS INC.
SCOTT 
 
KAHN 
EXECUTIVE OFFICER
DIOPSYS INC   |  STARTON THERAPEUTICS INC.
NINTIN 
 
KAUSHAL 
DIRECTOR
CHEMIOCARE INC.
NITIN 
 
KAUSHAL 
DIRECTOR
PATIENT HOME MONITORING CORP.   |  CONVALO HEALTH INTERNATIONAL, CORP.   |  HASHCHAIN TECHNOLOGY INC.   |  VIEMED HEALTHCARE, INC.   |  CANNAMERICA BRANDS CORP.   |  VALENS GROWORKS CORP.   |  CHEMIOCARE INC.   |  FLOWER ONE HOLDINGS INC.   |  STARTON THERAPEUTICS INC.   |  HIGH TIDE INC.
PEDRO 
 
LICHTINGER 
EXECUTIVE OFFICER, DIRECTOR
VELCERA, INC.   |  BIOTIME INC   |  ASTERIAS BIOTHERAPEUTICS, INC.   |  GEMPHIRE THERAPEUTICS INC.   |  CHEMIOCARE INC.   |  STARTON THERAPEUTICS INC.
PEDRO 
 
LICHTINGER WAISMAN 
EXECUTIVE OFFICER, DIRECTOR
STARTON THERAPEUTICS INC.
JAMIE 
 
OLIVER 
EXECUTIVE OFFICER
ELION ONCOLOGY, INC.   |  STARTON THERAPEUTICS INC.
LITSA 
 
PERPERIDIS 
PROMOTER
STARTON THERAPEUTICS INC.
FOTIOS 
 
PLAKOGIANNIS 
DIRECTOR
AEQUUS PHARMACEUTICALS INC.   |  CHEMIOCARE INC.   |  STARTON THERAPEUTICS INC.
ROMAN 
 
ROGOL 
DIRECTOR
CHEMIOCARE INC.
CIDNEE 
 
VAYKOVICH 
EXECUTIVE OFFICER, DIRECTOR
CHEMIOCARE INC.   |  1219014 B.C. LTD.   |  STARTON THERAPEUTICS INC.
PEDRO 
 
WAISMAN 
EXECUTIVE OFFICER, DIRECTOR
STARTON THERAPEUTICS INC.
ROY 
 
WALDON 
DIRECTOR
CHEMIOCARE INC.
ROY 
 
WALDRON 
DIRECTOR
STARTON THERAPEUTICS INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2024-10-22
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2024-10-10 
2023-10-13
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-10-01 
2023-04-13
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-03-31 
2023-01-25
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-01-18 
2022-02-16
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2022-02-11 
2021-11-22
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2021-10-19 
2021-05-26
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-03-03 
2020-01-13
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2019-12-20 
2018-07-02
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2018-04-04 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#